Containing Or Obtained From A Tree Having Matured Height Of At Least Two Meters Patents (Class 424/769)
  • Patent number: 12011496
    Abstract: The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light- and/or air-blocking packaging.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: June 18, 2024
    Assignee: Tracie Martyn International, Inc.
    Inventor: Marius Morariu
  • Patent number: 12005075
    Abstract: Combination of dry extract of Rhodiola, dry extract of Trubulus terrestris, dry extract of Undaria pinnatifida, Moringa oleifera, folic acid and vitamin B12 in the form of food supplement for mitigating woman's disorders caused by ageing.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: June 11, 2024
    Assignee: CRISTALFARMA S.R.L.
    Inventors: Maria Cristina Del Bono, Francesco Bonomo
  • Patent number: 11992545
    Abstract: Aqueous cosmetic compositions comprising at least 20% by weight of an aqueous component and a lipophilic component characterized in that the lipophilic component comprises at least one ester selected from neopentylglycol dipelargonate, glycerol tripelargonate, pentaerythritol tetrapelargonate or mixtures thereof.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: May 28, 2024
    Assignee: NOVAMONT S.P.A.
    Inventors: Luigi Capuzzi, Francesca Digioia, Vanessa Bramati, Federica Carlomagno, Alessandra Cominetti
  • Patent number: 11980664
    Abstract: Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 14, 2024
    Assignee: ALLOVATE, LLC
    Inventors: Michael Nelson, Erick Berglund
  • Patent number: 11911347
    Abstract: The present invention is in the field of antioxidants and relates to cosmetic or pharmaceutical, preferably dermatological, compositions or homecare product comprising or consisting of a synergistic combination of a specific antioxidant and an effective amount of 1,2-heptanediol and/or 2,3-heptanediol or of a specific alkanediol or a mixture of two or more different specific alkanediols and the use of said compositions as a cosmetic, for personal care, as a pharmaceutical or homecare product, in particular for scavenging reactive oxygen species (ROS), for inhibition matrix metalloproteinases expression and/or for inhibiting interleukin 8 (IL-8) secretion.
    Type: Grant
    Filed: April 14, 2023
    Date of Patent: February 27, 2024
    Assignee: Symrise AG
    Inventors: Nikolas Bugdahn, Sven Siegel, Sabine Lange, Dominik Stuhlmann
  • Patent number: 11896708
    Abstract: This invention illustrates a composition which has a high antioxidant power in cosmetic products. The composition includes a combination of two critical ingredients, originating from two natural superfood products: olive and kale. This current technology utilizes the sprout of kale, instead of the whole plant, as one ingredient. In the perspective of olive extract, it is either in the form of a concentrated liquid syrup of olive tree and leaf, which is enriched with natural polyphenols, especially with high content of hydroxytyrosol, or in the form of pure liquid hydroxytyrosol. An enhanced antioxidant power is observed when incorporating the kale sprouts together with the olive leaf extract.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: February 13, 2024
    Assignee: Barnet Products LLC
    Inventors: Nickolas Huss, Yiming Lu, Rossana Lanza
  • Patent number: 11891576
    Abstract: Processes for obtaining substances from bark, especially bark high in suberin and lignin, which substances can be used for preparing biofuels are disclosed. The processes use a solvent system for dissolving the substances, which system can be recycled in the process. The solvent system comprises a base selected from tertiary aliphatic amines A composition comprising bark and the solvent system, which can be used in the processes, is also disclosed.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: February 6, 2024
    Assignee: KAT2BIZ AB
    Inventors: Joseph Samec, Ivan Kumaniaev
  • Patent number: 11849727
    Abstract: Control or repellency of biting arthropods, particularly biting insects, is accomplished by bringing the biting arthropods into contact with combinations of compounds identical or related to those found on human/animal skin or in plants acting synergistically with one another, or in combination with conventional repellents like N,N-diethyl-3-methylbenzamide (DEET®), para-menthane-3,8-diol (PMD), sec-butyl-2-(2-hydroxyethyl) piperidine carboxylate (“Picaridin”), or other nitrogen containing repellents selected from amines, amides and nitrogen containing heterocyclic compounds, or any synergistic combination of DEET®, PMD, Picaridin, or other nitrogen containing repellents selected from amines, amides and nitrogen containing heterocyclic compounds.
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: December 26, 2023
    Assignee: BEDOUKIAN RESEARCH, INC.
    Inventor: Robert H. Bedoukian
  • Patent number: 11839208
    Abstract: The present invention is directed to use of cannabidiol and compositions thereof as an anti-bacterial agent against multi-drug resistant bacteria such as Pseudomonas aeruginosa.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: December 12, 2023
    Assignee: PHARMOTECH SA
    Inventor: Rodin Aeschbach
  • Patent number: 11839252
    Abstract: A convenient after care cleanser and application method for eyelash extensions allows for easy application, extension of the longevity of the lashes, elimination of protein build-up that eventually accumulates on the lashes, and other benefits.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: December 12, 2023
    Inventor: Cherie L. Dobbs
  • Patent number: 11820865
    Abstract: The invention relates to vicinal diol ether derivatives of certain polyether polymers, compositions comprising the same, and methods of making the same via reaction with substituted or unsubstituted epoxides, and methods of using the same.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: November 21, 2023
    Assignee: P2 SCIENCE, INC.
    Inventors: Patrick Foley, Ashoke Bhattacharjee, Tania Salam, Matthew Alan Garcia
  • Patent number: 11801276
    Abstract: Provided are a microorganism having an ability to degrade ethanol and acetaldehyde, and a composition and a kit each including the microorganism.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: October 31, 2023
    Assignee: Medytox Inc.
    Inventors: Young In Kim, Tai Hoon Kim, Hyei Jin Dong, Woo Jin Choi, Hyun Uk Jeong, Seong Gon Hong, Dong Wook Ryu
  • Patent number: 11793754
    Abstract: A nanoemulsion, and a method of preparing the nanoemulsion is disclosed. The nanoemulsion includes sodium hypochlorite (NaOCl), chlorhexidine (CHX), and a self-nanoemulsifying delivery system (SNEDS) which further includes at least one oil, at least one surfactant, and at least one co-surfactant, wherein no parachloroaniline is present in the nanoemulsion after 1 hour at room temperature.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: October 24, 2023
    Assignee: King Abdulaziz University
    Inventor: Laila Ahmed Salim Bahammam
  • Patent number: 11772030
    Abstract: A miniature gas detection and purification device is disclosed for a user to carry with himself, and includes a main body, a purification module, a gas guider and a gas detection module. The gas detection module detects gas of surrounding environment to obtain a gas detection datum, and controls the gas guider to be operated according to the gas detection datum, so that gas is inhaled into the main body and flows through the purification module for filtration and purification, and the gas purified is finally guided to a region close to the user.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: October 3, 2023
    Assignee: MICROJET TECHNOLOGY CO., LTD.
    Inventors: Hao-Jan Mou, Yung-Lung Han, Chi-Feng Huang, Chang-Yen Tsai, Wei-Ming Lee, Chun-Yi Kuo, Yang Ku
  • Patent number: 11771730
    Abstract: The present invention relates to a product containing an extract of Rhodiola and an extract of Astragalus as products to be combined for simultaneous administration, separately or staggered over time, in the treatment of a neurodegenerative disease, and in particular for the treatment of Alzheimer's disease and Parkinson's disease.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: October 3, 2023
    Assignee: HUMAN BY NATURE
    Inventor: Gérald Goudet
  • Patent number: 11755996
    Abstract: A method for adjudicating reimbursement for allergens includes obtaining National Drug Codes (NDC's) for a plurality of allergens, storing in a central control database the obtained NDC's in association with an associated AWP and associated information for the allergen, which associated information includes translation information to allow practitioners to determine from a desired diluted level and number of doses of a desired NDC carrying antigen and a known dilution procedure how to translate back to the amount of base concentration of the NDC carrying antigen used to create the desired diluted level and number of doses, and determining if any of the NDC's in the central control database are contained within the third-party database and, if not, transferring the associated NDC's not in the third-party database to the third-party database.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: September 12, 2023
    Assignee: ROCA MEDICAL LTD.
    Inventors: James Strader, Jovan Hutton Pulitzer
  • Patent number: 11752090
    Abstract: A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Chamaecrista mimosoides, wherein the composition reduces tyrosinase activity in the skin, increases antioxidant activity in the skin, and/or increases skin moisture content.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: September 12, 2023
    Assignee: MARY KAY INC.
    Inventors: Tiffany Florence, David Gan, Michelle Hines
  • Patent number: 11741606
    Abstract: A digital imaging method of analyzing pixel data of an image of a user's body for determining a user-specific hair removal efficiency value after removing hair is disclosed. The digital imaging method includes: aggregating training images of respective individuals' bodies after removing hair; training, using the pixel data of the training images, a hair removal efficiency model to determine hair removal efficiency values associated with a degree of hair removal efficiencies ranging from a least efficient to a most efficient; receiving an image of a user's body after removing hair; analyzing by the user image using the hair removal efficiency model to determine a user-specific hair removal efficiency value; generating a user-specific electronic recommendation designed to address a feature identifiable within the pixel data of the user's body based on the user-specific hair removal efficiency value; and rendering the recommendation on a display screen of a user computing device.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: August 29, 2023
    Assignee: The Gillette Company LLC
    Inventors: Susan Clare Robinson, Leigh Knight
  • Patent number: 11730787
    Abstract: The present invention relates to a method for treating HIV/AIDS complications including administering a first Chinese herbal medicine composition to a subject in need; wherein the first Chinese herbal medicine composition is an extract of a first mixture including Polygonatum sibiricum, Astragalus membranaceus, Panax ginseng, Liriope spicata, Schisandra chinensis, Ziziphus zizyphus, Cornus officinalis, Fallopia multiflora, and Salvia miltiorrhiza.
    Type: Grant
    Filed: November 8, 2021
    Date of Patent: August 22, 2023
    Inventors: Ying-Chieh Huang, Chen-Yu Lee
  • Patent number: 11607424
    Abstract: Compositions and methods for protecting bees from toxins and for preventing or decreasing colony collapse are provided. The compositions comprise carbon microparticles which, when ingested by bees, increase their survival after exposure to toxins such as pesticides.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: March 21, 2023
    Assignee: Washington State University
    Inventors: Waled Suliman, Brandon Hopkins, Manuel Garcia-Perez
  • Patent number: 11506648
    Abstract: Disclosed is a detection method for quality grade of traditional Chinese medicine (TCM), including: detecting the levels of quality control index components of TCM and efficacy-related in vitro activity by establishing a correlation between principal components of TCM and in vitro activity; determining the state of sample cluster by principal component analysis; constructing a logistic regression model of quality grade versus index components and bioactivity and establishing corresponding grade detection formulas of Chinese medicinal materials by fitting a large number of sample data for Chinese medicinal materials from different places of origin and batches. The method of the present invention realizes the mathematical expression of a standard for quality difference of TCM, and provides a feasible solution for the industrialized evaluation of quality grades of Chinese medicinal materials or herbal slices finally.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: November 22, 2022
    Assignee: SHAANXI UNIVERSITY OF CHINESE MEDICINE
    Inventors: Zhishu Tang, Yanru Liu, Zhongxing Song, Dahai Jiang, Ningjuan Yang, Aibing Chang, Xiaohong Li
  • Patent number: 11419847
    Abstract: Pharmaceutical micronutrient composition including mixture D in this study helps to mitigate, inhibit, prevent and stop diseases caused by viral infections. The middle east respiratory syndrome-related coronavirus and severe acute respiratory syndrome-related coronavirus as well as their variants and mutants affecting mammals and causing infection are successfully treated using mixture D. Mixture D contains key micronutrients such as an ascorbate, N-acetylcysteine, theaflavins, resveratrol, cruciferous plant extracts, curcumin, quercetin, naringenin, and baicalin and a combination thereof. Additional micronutrients were tested with Mixture D and seemed to have beneficial effects.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: August 23, 2022
    Inventor: Matthias W Rath
  • Patent number: 11351102
    Abstract: The present invention discloses a method for protecting mammalian skin against the harmful effects of UV radiation and environmental pollutants, using one or plant actives selected from group comprising a composition comprising not less than 10% w/w oroxylin A, not less than 10% w/w baicalein and not less than 2% w/w chrysin; 95% w/w oxyresveratrol; 95% w/w tetrahydrocurcumin; 90% w/w pterostilbene and a composition comprising at least 10% w/w ?-glucogallin and at least 10% w/w total mucic acid gallates. The invention also discloses a method for cleansing and rejuvenating mammalian skin, exposed to environmental pollutants and UV radiation using the aforesaid plant actives.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: June 7, 2022
    Assignee: SAMI-SABINSA GROUP LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur
  • Patent number: 11337942
    Abstract: Provided are a medical ointment of a novel combination containing paeonol and a pharmaceutical use thereof. The medical ointment of a novel combination includes paeonol and panthenol, and further includes at least one selected from Centella asiatica, coenzyme Q10, neomycin sulfate, and pharmaceutically acceptable salts of these. In the medical ointment of a novel combination, specific ingredients that are effective for local pain relief are mixed with ingredients having other effects in a certain ratio to address the problems of the cut treatment ointment of the related art, so that excellent effects may be obtained in relieving itching and reducing pain while inflammation is effectively treated.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: May 24, 2022
    Assignee: GENTRIBIO INC.
    Inventors: Chang Keun Yoon, Hong Gyum Kim
  • Patent number: 11331265
    Abstract: The present disclosure is directed to a method for producing an olive branch extract having a high oleuropein content. The method includes crushing at least a portion of dried olive branch and extracting olive branch extract from the crushed olive branch with an extraction solvent. The olive variety is at least one selected from Lucca, Mission, and Nevadillo Blanco. The added branch amount of olive branch to the extraction solvent is 10% by weight or more, the extraction solvent is 30% to 50% 1,3-butylene glycol, and the extraction is performed at a temperature in a range of 70° C. to 80° C.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: May 17, 2022
    Assignee: SHODOSHIMA HEALTHYLAND CO., LTD.
    Inventors: Toshihiro Yagyu, Norihito Kishimoto, Kana Iwata
  • Patent number: 11229589
    Abstract: Described herein is an invention that includes a spreadable conditioning composition comprising a blend of: a branched hydrocarbon and an ester having a kinematic viscosity of less than or equal to about 100 centistokes. The composition may be natural, for example, if each of the branched hydrocarbon and the ester are independently vegetable-derived. In addition, the composition may lack ingredients that are derived from a palm oil. In an embodiment, the composition is a blend of hydrogenated farnesene and an esters selected from glyceryl triheptanoate, dicapryl succinate, heptyl undecylenate, and mixtures thereof. The composition exhibits an average spreading velocity of about 4 to about 8. Also disclosed are formulations for use in products of personal care, home/institutional care, industry, pharmaceutical and medical and veterinary care and related methods.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: January 25, 2022
    Assignee: INOLEX INVESTMENT CORPORATION
    Inventor: Rocco V. Burgo
  • Patent number: 11191744
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Vivien Chavanelle, Florian Le Joubioux, Pascal Sirvent, Thierry Maugard
  • Patent number: 11166965
    Abstract: The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: November 9, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Marie Noelle Horcajada, Fanny Membrez, Elizabeth Offord Cavin
  • Patent number: 11058737
    Abstract: The present invention is directed to a new kind of medicinal value or health care function of Eurycoma longifolia extracts, particularly in the treatment or alleviation symptoms and/or conditions associated to hormonal imbalance in females, including menopause and its related symptoms. In one aspect, the present invention discloses the use of a composition comprising a therapeutically effective amount of Eurycoma longifolia extract in the manufacture of a medicament for the alleviation of symptoms and/or conditions associated to hormonal imbalance in females, including menopause and its related symptoms. The alleviation of the symptoms and/or conditions according to the present invention is characterised by inducing a change in the hormonal contents of estrogen, progesterone, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Also disclosed is the use of a pharmaceutical composition comprising the therapeutically effective amount of Eurycoma longifolia extract.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: July 13, 2021
    Assignee: BIOTROPICS MALAYSIA BERHAD
    Inventors: Tengku Shahrir Tengku Adnan, Annie George, Sasikala M. Chinnappan
  • Patent number: 10967059
    Abstract: Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: April 6, 2021
    Assignee: Allovate, LLC
    Inventors: Michael Nelson, Erick Berglund
  • Patent number: 10967019
    Abstract: A use of an emblica extract in preparing a pharmaceutical composition for protecting mitochondria in retina is provided. When the pharmaceutical composition, which comprises the emblica extract, is provided to retinal cells, a use of the pharmaceutical composition comprises improvement of the ability of performing the oxidative phosphorylation for the synthesis of the adenosine triphosphate (ATP) by the mitochondria in the retinal cells under or exposed to ultraviolet light, and improvement of the coupling efficiency of the synthesis of the adenosine triphosphate by the mitochondria.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: April 6, 2021
    Assignee: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Shun-Chieh Yang, Man-Ching Shen
  • Patent number: 10961221
    Abstract: The present application relates to novel substituted piperidinyltetrahydroquinolines, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardial vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: March 30, 2021
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Eva Maria Becker-Pelster, Philipp Buchgraber, Anja Buchmüller, Karen Engel, Volker Geiss, Andreas Göller, Herbert Himmel, Raimund Kast, Andreas Knorr, Dieter Lang, Gorden Redlich, Carsten Schmeck, Hanna Tinel, Frank Wunder
  • Patent number: 10953055
    Abstract: An extract of seeds of Emblica officinalis which has triterpenoids and hydroxycinnamic acids is provided. A blend of extracts of seeds of Emblica officinalis which includes an extract of seeds of Emblica officinalis having triterpenoids and hydroxycinnamic acids and an extract of seeds of Emblica officinalis having fatty acids, such as, alpha linolenic acid, linoleic acid and oleic acid is provided. Methods of preparing the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided. Methods of treatment administering the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 23, 2021
    Inventor: Benny Antony
  • Patent number: 10953057
    Abstract: The present invention provides an egg-laying rate-improving agent for egg-laying hens, quails, or broiler breeders, the egg-laying rate-improving agent being characterized by comprising unheated cashew nut shell liquid, heated cashew nut shell liquid, anacardic acid, cardanol, and/or cardol.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: March 23, 2021
    Assignee: IDEMITSU KOSAN CO., LTD.
    Inventors: Eiji Iwamoto, Yuji Shizuno, Yasuhiro Suzuki
  • Patent number: 10653742
    Abstract: The present invention relates to a phytocomplex or natural concentrate rich in polyphenolic compounds, such as hydroxytyrosol and 3,4-DHPA-EDA, derived from the vegetation waters of oil-bearing olives or from olive pomace resulting from the olive milling process for use in the treatment and prevention of angiogenesis and inflammation. In particular, the angiogenesis and inflammation to which reference is made is pathologic angiogenesis and inflammation, for example that which sustains the development and spread of a tumor or angiogenesis and inflammation tied to non-tumor pathologies. The present invention further relates to a beverage comprising the polyphenol concentrate and the use thereof in the treatment and prevention of angiogenesis and inflammation.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: May 19, 2020
    Assignee: FATTORIA LA VIALLA DI GIANNI, ANTONIO E BANDINO LO FRANCO—SOCIETA′ AGRICOLA SEMPLICE
    Inventors: Gianni Lo Franco, Adriana Albini, Massimo Pizzichini, Teresa Rossi, Antonino Bruno, Arianna Pagani
  • Patent number: 10603270
    Abstract: The present disclosure provides a mixture of sugar apple and rosemary extracts, optionally in combination with prickly ash extract, for use as skin care compositions.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: March 31, 2020
    Assignee: Unigen, Inc.
    Inventors: Lidia Alfaro Brownell, Min Chu, Brandon Corneliusen, Mei-Feng Hong, Ji-Hye Hwang, Eu-Jin Hyun, Qi Jia, Ping Jiao, Mi-Ran Kim, Bo-Su Lee, Young-Chul Lee, Jeong-Bum Nam, Mi-Sun Oh, Mesfin Yimam
  • Patent number: 10596105
    Abstract: A nasal spray or therapy solution is provided having organic glycerin; an organic preservative system containing glycerin, citrus reticulata fruit extract, citrus aurantium amara fruit extract, citrus aurantium sinensis peel extract, ascorbic acid, citric acid, lactic acid, water; sodium chloride; water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: March 24, 2020
    Inventors: Max Spielberg, David Johnson
  • Patent number: 10568877
    Abstract: Provided herein are quinolinone derivatives and their uses as antiviral drugs, for example, for treatment of HSV-1 infection. Also provided herein are pharmaceutically acceptable compositions comprising the quinolinone derivatives and the uses of the composition in the treatment of diseases caused by HSV-1 virus.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: February 25, 2020
    Assignee: OCEAN UNIVERSITY OF CHINA
    Inventors: Changlun Shao, Changyun Wang, Rufang Xu, Feifei Guan, Meiyan Wei
  • Patent number: 10532015
    Abstract: An oral care composition comprising zinc phosphate, stannous fluoride, arginine or lysine and an organic acid buffer system, as well as methods of using the same.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: January 14, 2020
    Assignee: Colgate-Palmolive Company
    Inventors: Aarti Rege, Michael Prencipe
  • Patent number: 10532022
    Abstract: The present invention relates to processes for producing treated olive mill process water (OMPW). In some exemplary embodiments, the treated OMPW is used in the preparation/production of body care products.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: January 14, 2020
    Assignees: The United States of America, as represented by The Secretary of Agriculture, McEvoy of Marin, LLC
    Inventors: Rebecca R Milczarek, Jeffrey A Creque, John Bailey, Ellen Roggemann
  • Patent number: 10524990
    Abstract: An oral care composition comprising zinc phosphate, sodium fluoride, stannous pyrophosphate, and an organic acid buffer system, as well as methods of using the same.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: January 7, 2020
    Assignee: Colgate-Palmolive Company
    Inventor: Aarti Rege
  • Patent number: 10406087
    Abstract: An oral care composition comprising zinc phosphate, stannous fluoride, arginine or lysine and an organic acid buffer system, as well as methods of using the same.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: September 10, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Aarti Rege, Michael Prencipe, Marc Estriplet
  • Patent number: 10398661
    Abstract: The invention provides methods for classifying a cancer as susceptible to transmembrane prostate androgen induced (TMEPAI)-directed therapies, and methods for treating such cancers. The field of the invention pertains generally to medicine, pathology and oncology. More particularly, it addresses the treatment of breast cancer, such as triple-negative breast cancer, using a transmembrane prostate androgen induced (TMEPAI)-directed therapy.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: September 3, 2019
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Pothana Saikumar, Prajjal Kanti Singha
  • Patent number: 10391135
    Abstract: A method of treating an amyloid disease by administration of cactus mucilage extract from Opuntia ficus-indicia is presented. Both gelling and non-gelling cactus mucilage extracts were found to induce changes in the secondary structures of the amyloid beta peptides thus interfering with formation of A? fibrils and aggregation of A? fibrils into plaques.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: August 27, 2019
    Assignee: University of South Florida
    Inventors: Norma A. Alcantar, David Morgan, Zeinab Veisi, Leonid Breydo, Vladimir N. Uversky, Ryan G. Toomey, Tunan Peng, Eva Stephanie Lobbens
  • Patent number: 10383906
    Abstract: A method for treating skin diseases, wherein a composition having an effective amount of mangosteen rind extract is administered.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: August 20, 2019
    Assignee: XANTHO BIOTECHNOLOGY CO., LTD.
    Inventors: Jia-Ming Chang, Pei-Yi Tsai, Ku-Cheng Chen
  • Patent number: 10342834
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: July 9, 2019
    Assignee: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Szu-Ting Liu
  • Patent number: 10286025
    Abstract: The present invention provides a pharmaceutical composition or a food composition containing combined extracts comprising Schisandrae fructus, Eucommiae cortex and Lycii fructus as active ingredients for preventing or treating metabolic bone diseases. The composition of the present invention does not have side effects as it is a substance derived from natural sources; is effective on osteogenesis in ovariectomized mice; increases the bone content and the bone formation index of serum in real animal model; and reduces the bone resorption index so as to be useful for preventing or treating metabolic bone diseases.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: May 14, 2019
    Assignee: University-Industry Cooperation Group of Kyung Hee University
    Inventors: Woong Mo Yang, Mi Hye Kim
  • Patent number: 10258660
    Abstract: The present invention provides a method of producing an olive leaf extract that contains a high concentration of oleuropein. A method of producing an olive leaf extract comprises a first step of grinding dried olive leaves and a second step of mixing grapes with the ground olive leaves and then extracting an olive leaf extract using an extraction solvent. In the second step, the extraction solvent is water, alcohol, or a combination thereof, and extraction is performed at 70° C. or higher.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: April 16, 2019
    Assignee: SHODOSHIMA HEALTHYLAND CO., LTD.
    Inventors: Toshihiro Yagyu, Norihito Kishimoto
  • Patent number: 10245325
    Abstract: Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: April 2, 2019
    Assignee: JDS Therapeutics, LLC
    Inventor: James R. Komorowski
  • Patent number: 10220046
    Abstract: Provided herein are compositions and methods for the treatment of diseases, such as hyperproliferative diseases, employing compounds formulated for pharmaceutical and research use via nanoparticles.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: March 5, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Anna Schwendeman, Mark Cohen, Chitra Subramanian, Rui Kuai, Dan Li, Peter White, James Moon